semaglutide 0.1 mg Novo Nordisk's weight-loss pill wins FDA approval GLP-1 - For Weight Loss

Semaglutide, by contrast, activates GLP-1 receptors throughout your bodytriggering appetite signals in the brain, slowing stomach emptying, and improving insulin secretion only when blood sugar is elevated

Additional metabolic effects include stimulation of fatty acid oxidation, inhibition of gluconeogenesis, and increased energy expenditure

The pharmacodynamics of semaglutide are characterized by a prolonged half-life of approximately one week, allowing for once-weekly dosing

Walking, swimming, or strength training all help improve insulin sensitivity and support weight loss

Semaglutide reduces hunger but does not eliminate food cravings entirely, especially for highly palatable ultra-processed foods high in sugar and fat

Effects of a Glucagon-like Peptide-1 Mimetic (Exenatide) in Healthy Cats